Efficacy and Safety of Silicone Cream Containing Allium Cepa Extract

NCT ID: NCT04233320

Last Updated: 2020-01-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

22 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-02-01

Study Completion Date

2020-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objectives of this study were to evaluate efficacy and safety of silicone cream containing Allium Cepa extract in post-cesarean surgical scars treatment. Post-cesarean surgical scars were equally seperated into 2 parts (left part and right part). Silicone cream containing Allium Cepa extract or commercial scar gel was ramdomly assigned to apply on left part or right part of the scar. They will be applied 2 times per day (morning and evening) for 3 months. Patient and Observer Scar Assessment Scale (POSAS) , Vancouver scar scale (VSS), melanin index, and erythema index (using cutometer) were used for scar evaluation at 0, 1,2,and 3 months. Moreover, adverse effects were also observed.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cicatrix

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

silicone cream containing Allium Cepa extract

Silicone cream containing Allium Cepa extract will be applied on half of post-cesarean surgical scars 2 times per day for 3 months.

Group Type EXPERIMENTAL

silicone cream containing Allium Cepa extract

Intervention Type DEVICE

silicone cream containing Allium Cepa extract contains 10% of Allium cepa bulb extract.

commercial scar gel

Commercial scar gel will be applied on half of post-cesarean surgical scars 2 times per day for 3 months.

Group Type ACTIVE_COMPARATOR

Commercial scar gel

Intervention Type DEVICE

Commercial scar gel is a topical silicone gel. It contains cyclic and polymeric siloxanes and Vitamin C ester.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

silicone cream containing Allium Cepa extract

silicone cream containing Allium Cepa extract contains 10% of Allium cepa bulb extract.

Intervention Type DEVICE

Commercial scar gel

Commercial scar gel is a topical silicone gel. It contains cyclic and polymeric siloxanes and Vitamin C ester.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18-40 years
* Have Post-Cesarean Surgical Scars at least 1 month
* REEDA scale = 0 score
* Able to read and write Thai
* Able to follow the research plan
* Able to meet all the researchers throughout the period of participation in the project

Exclusion Criteria

* Apply other topical application at the post-cesarean surgical scars within 2 weeks before participating in the study and during the study
* There is radiation in the area of the post-cesarean surgical scars
* Chronic skin diseases such as psoriasis, chronic dermatitis, allergies
* Immune deficient or use immunosuppressants within 2 weeks before participating in the study and during the study
* Have a history of silicone allergy or onion extract
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Chulalongkorn University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Pornanong Aramwit, Pharm.D., Ph.D

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Pornanong Aramwit, Ph.D

Role: CONTACT

+66899217255

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

547/62

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Scars After Central Venous Catheters
NCT01113125 UNKNOWN PHASE3